Mistral Therapeutics, Inc. — Form D/A
Mistral Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2014-06-27. The offering totals $19.5M, of which $10.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-06-27
- Form: D/A
- Accession: 0001520711-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.5M
- Amount sold: $10.5M
- Remaining: $9.0M
- Investors: 3
- Date of first sale: 2011-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-161543
Issuer
- Name: Mistral Therapeutics, Inc.
- CIK: 0001520711
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 5871 OBERLIN DRIVE, SAN DIEGO, CA, 92121
- Phone: (858) 224-7700
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| BRADLEY J BOLZON | Director | MENLO PARK, CA |
| THOMAS A COLL | Executive Officer | SAN DIEGO, CA |
| Petpiboon Prasit | Executive Officer | San Diego, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Jerel Davis | Director | Alameda, CA |
| Bradley Bolzon | Director | SAN DIEGO, CA |
| Petpiboon Prasit | Director | San Diego, CA |
| Jeremy Caldwell | Executive Officer | Seattle, WA |
Other filings by this issuer (3)
More